CERo Therapeutics Holdings Inc (NASDAQ: CERO) is -89.72% lower on its value in year-to-date trading and has touched a low of $0.53 and a high of $178.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CERO stock was last observed hovering at around $0.60 in the last trading session, with the day’s gains setting it 0.02%.
Currently trading at $0.62, the stock is -17.12% and -49.41% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.16 million and changing 3.35% at the moment leaves the stock -93.22% off its SMA200. CERO registered -99.66% loss for a year compared to 6-month loss of -93.64%. The firm has a 50-day simple moving average (SMA 50) of $1.21966 and a 200-day simple moving average (SMA200) of $9.107615.
The stock witnessed a -33.66% gain in the last 1 month and extending the period to 3 months gives it a -75.22%, and is -19.87% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 13.33% over the week and 14.55% over the month.
CERo Therapeutics Holdings Inc (CERO) has around 8 employees, a market worth around $3.32M and $0.00M in sales. Distance from 52-week low is 15.59% and -99.65% from its 52-week high. The company has generated returns on investments over the last 12 months (-11090.59%).
21.0 institutions hold shares in CERo Therapeutics Holdings Inc (CERO), with institutional investors hold 7.84% of the company’s shares. The shares float is at 2.06M with Short Float at 16.61%. Institutions hold 6.59% of the Float.
CERo Therapeutics Holdings Inc (CERO) Insider Activity
The most recent transaction is an insider sale by YK Bioventures Opportunities G, the company’s 10% Owner. SEC filings show that YK Bioventures Opportunities G sold 2,998,908 shares of the company’s common stock on Dec 13 ’24 at a price of $0.06 per share for a total of $0.18 million. Following the sale, the insider now owns 13.01 million shares.
CERo Therapeutics Holdings Inc disclosed in a document filed with the SEC on Dec 12 ’24 that YK Bioventures Opportunities G (10% Owner) sold a total of 1,614,541 shares of the company’s common stock. The trade occurred on Dec 12 ’24 and was made at $0.07 per share for $0.11 million. Following the transaction, the insider now directly holds 16.0 million shares of the CERO stock.
Still, SEC filings show that on Dec 11 ’24, YK Bioventures Opportunities G (10% Owner) disposed off 1,343,801 shares at an average price of $0.08 for $0.11 million. The insider now directly holds 17,618,618 shares of CERo Therapeutics Holdings Inc (CERO).
